Ophthalmology
PulseSight Therapeutics is focused on clinical research in ophthalmology, with activity centered on dry age-related macular degeneration. Its trial portfolio reflects interest in retinal disease and age-related visual impairment.
- Dry age-related macular degeneration
- Retinal degeneration
- Vision loss
The sponsor’s research activity is directed toward therapeutic areas relevant to macular health and degenerative eye disease.
Retinal Disorders
The clinical research landscape includes investigation of conditions affecting the retina and central vision, with emphasis on disorders associated with progressive structural and functional decline.
- Macular degeneration
- Central vision impairment
- Age-related ocular disease
These areas align with therapeutic interest in preserving visual function in patients with degenerative retinal conditions.
Age-Related Eye Disease
PulseSight Therapeutics shows interest in age-related eye disease, particularly disorders that emerge later in life and affect reading, recognition, and daily visual tasks.
- Senescent ocular degeneration
- Macular atrophy
- Visual function decline
The sponsor’s work is situated within therapeutic efforts addressing the unmet needs of patients with progressive macular pathology.
